Yale Bulletin and Calendar

March 4, 2005|Volume 33, Number 21


BULLETIN HOME

VISITING ON CAMPUS

CALENDAR OF EVENTS

IN THE NEWS

BULLETIN BOARD

CLASSIFIED ADS


SEARCH ARCHIVES

DEADLINES

DOWNLOAD FORMS

BULLETIN STAFF


PUBLIC AFFAIRS HOME

NEWS RELEASES

E-MAIL US


YALE HOME PAGE


Substances in urine help to identify life-threatening preeclampsia in
pregnant women, researchers find

Researchers at the School of Medicine have found that specific substances in the urine of pregnant women could serve as a screening/diagnostic tool for preeclampsia (hypertension and proteinuria during pregnancy).

The study is published in the March issue of American Journal of Obstetrics and Gynecology.

"Preeclampsia is one of the most common causes of maternal mortality in the United States, but establishing a correct diagnosis can be very difficult, especially in women with hypertension prior to pregnancy," says lead author Dr. Catalin Buhimschi, assistant professor in the Department of Obstetrics, Gynecology and Reproductive Sciences.

Buhimschi and his colleagues developed a new algorithm to calculate the ratio for the presence or absence of three specific proteins that are normally secreted by human placenta. They examined samples of urine and blood from 132 women, some of whom had other causes of hypertension. The ratio between two of the proteins correctly identified all the women who had severe preeclampsia.

"It will take several years to develop a new diagnostic test," says Buhimschi. "Many factors are present in the serum and blood, but only the relationship between them has diagnostic significance."

The proteins studied were vascular endothelial growth factor (VEGF), placental growth factor (PlGF) and their soluble VEGF receptor (sFlt-1). The ratio of sFlt-1 and PlGF had a high sensitivity (88%) and specificity (100%) for identifying severe preeclampsia, and was more accurate than proteinuria alone.

Buhimschi says current tests such as liver function, proteinuria and platelet count are neither accurate nor sensitive, and results can be confusing, placing women at risk of giving birth prematurely. The current treatment is delivery of the fetus regardless of gestational age. These results provide scientists with a better understanding of the mechanisms of preeclampsia, he notes.

Co-authors are Dr. Errol R. Norwitz, Dr. Edmund Funai, Dr. Susan Richman, Dr. Seth Guller, Dr. Charles J. Lockwood and Dr. Irina A. Buhimschi.

-- By Karen Peart


T H I SW E E K ' SS T O R I E S

Cost-saving measures net $3.5 million in six months


Professors honored for lifetime achievements

Student enjoys the high life

University to host events for area schoolchildren

Polak and Prown are honored with DeVane Medals for teaching

Substances in urine help to identify life-threatening . . .

Lawyers, legal scholars debate protection of Chinese media . . .

Psychiatrists are lauded for work on schizophrenia

Wilbon discusses goals, cheating and future of sports writing

Paintings 'retell true story of how we are to love each other's

Women's basketball coach steps down . . .

Study to explore drug's role in helping smokers quit without weight gai

Nursing student honored at Capitol Hill scholarship event


Bulletin Home|Visiting on Campus|Calendar of Events|In the News

Bulletin Board|Classified Ads|Search Archives|Deadlines

Bulletin Staff|Public Affairs|News Releases| E-Mail Us|Yale Home